The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Journal of Personalized Medicine · 10.04.2023 · 13 (4) · 652
DOI: 10.3390/jpm13040652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.04.2023. Verfasst von Anna Pisani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 290 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS.
Abstract (Originalsprache)
Brain-derived neurotrophic factor (BDNF) has a crucial function in the central nervous system and in sensory structures including olfactory and auditory systems. Many studies have highlighted the protective effects of BDNF in the brain, showing how it can promote neuronal growth and survival and modulate synaptic plasticity. On the other hand, conflicting data about BDNF expression and functions in the cochlear and in olfactory structures have been reported. Several clinical and experimental research studies showed alterations in BDNF levels in neurodegenerative diseases affecting the central and peripheral nervous system, suggesting that BDNF can be a promising biomarker in most neurodegenerative conditions, including Alzheimer’s disease, shearing loss, or olfactory impairment. Here, we summarize current research concerning BDNF functions in brain and in sensory domains (olfaction and hearing), focusing on the effects of the BDNF/TrkB signalling pathway activation in both physiological and pathological conditions. Finally, we review significant studies highlighting the possibility to target BDNF as a biomarker in early diagnosis of sensory and cognitive neurodegeneration, opening new opportunities to develop effective therapeutic strategies aimed to counteract neurodegeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Department of Neuroscience, Reproductive Sciences and Dentistry-Audiology Section, University of Naples Federico II, 80131 Naples, Italy.
- Department of Neuroscience, Reproductive Sciences and Dentistry-ENT Section, University of Naples Federico II, 80131 Naples, Italy.
ORCID-Profile: Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone
Förderung
- Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS
Zitieren
APA
Pisani, A., Paciello, F., Del Vecchio, V., Malesci, R., De Corso, E., Cantone, E., & Fetoni, A. R. (2023). The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration. Journal of Personalized Medicine, 13(4), 652. https://doi.org/10.3390/jpm13040652
Vancouver
Pisani A, Paciello F, Del Vecchio V, Malesci R, De Corso E, Cantone E, et al. The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration. Journal of Personalized Medicine. 2023;13(4):652. doi:10.3390/jpm13040652
BibTeX
@article{Pisani2023,
author = {Pisani, Anna and Paciello, Fabiola and Del Vecchio, Valeria and Malesci, Rita and De Corso, Eugenio and Cantone, Elena and Fetoni, Anna Rita},
title = {The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {4},
pages = {652},
doi = {10.3390/jpm13040652}
}
EUVIMED